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avaikxble publi&cd dara w&me the rrequcncy of this compbcadon. 
Fhich ~counred 6~38% ofdcalbr amonepalienlr in xhom if could be 
evaluated. We arc w~lerul lo h,,” for elrboralina on some or the 
~bon~uminp~olthe\ludy. whsh wul:nolall beindodedmlheanicle 
in order 1~1 m&c the lcngtb \uitablc ror publication. While the rtudy 
fdl\,honorfulfilling Koeh’\pu,lulatelforcaulalion,we believed that 
the queaion posed r*as or vilal impmancc IO clinician, caring for 
palien& with acute myocardial mfarclion. eip-ecially ar the time 
window for we or dvomhuly+ i\ exwndcd longer arter rymplom 
onlet We bcheved dtat the suppon orbnh the mela-analysis and uhe 
GlSSldalaforoura p-i& hyporhcsir bawd oncompellingpalhophyr- 
iolo$c ob\ervationr mandad our diswmination of the findings. 
Masse1 expresses conccrn that we do no! have primary daya on 
the individual patlentr in each trial. We ;yrce wnh his suggestion 
and have rubmilled requertr ror Informan on each indwidusl 
patient 10 mve~lipalorr from the 43 randomized controlled trials for 
which autop\y rater were no, known to br <.cO%. We wspec, ,hs, 
it may be Jdiicult for us 10 locale some ofthe inveatigalon involved 
in rludie, publirbed a~ long as 31 years ago. and for them 10 
retrowctwely rcconcmxl data sets on 25.6X padcntr inclusive or 
autopsy and demographic data for US in a Us3blc maimer. We are 
more optimnlic lhal a polentielly more iwwale source or informa. 
dun may be provided by analysis of subsers of padrnn rrom the 
*aemarmnal Study or infarct Survival.2 study 11, or the *nglo. 
Scandinavian Study or Earlv Thrombolvris (2) limtled to oatienlr 
Low Dose Amiodarone in Congestive 
Heart Failure 
We read wilb p.rcat inwest the article by Hamer and others (I) and 
the editorial comments by Challerjee 12) an treating patients with 
congerli”c heir, hilure with bW dorc .miudarunc. Wa hiwc km 
udlizine amiodarune for a numberofyearr in pxicms wtb complex 
ventricular arrhythmias and low ejection fraction and have sign& 
canlly decreered Ihe complexity or Ihe iarhylhmia. 85 confirmed bv 
relemclry and Holler mon~lor ewmmsl~oin pelformed before hor- 
pi! al dircbarge. A followup Holler monitor esaminildon is “budned 
spproxim:ttely 2 10 4 wcekr arter ho+d discharge 10 denermine the 
long-fen &iC.lCy of the drug. We have been able 10 manage Ihe 
arrhythmias wilh initial doses or400 to SW mgfday wnh a mnmw 
nance dose of 2W muday. If the arrhythrme breaks through. 
additional incwmcnt\ or amiadarone are given. A Holler wdy (I 
obtaiaed approxim;ltely 5 day\ after the initiation of therapy or the 
initiation of the final change m dosage. If the arrhythmia is under 
conlrol, Ihe patient is discharged on lbat dose of Ihe drug lowally 
:vV m&&y). A! Ihe lime orfollow-up. irlbe arrbylhmis condnoes to 
be under control. the dosage is again decreased to IW mglduy. 
Thcraoeudc efficacv is xconfirmcd bv u subseauent H&r m&or 
2 weeks after the last change in do&. 
If side effects do develop during long-term followup. our ap- 
preach h-s been 10 reduce the dosage of the drug by approx,mately 
5@%. Confirma,iun “r E”ntr”l ol :hc arrbydlmia is demonarated 2 
weeks later by a repeat Hoher study. Utilizing lhn melhod. we have 
round very few incidents or side e~eclr with the use of small do\es 
0r amiodarone. 
Amiudarone il also extremely eflective in padents with conges- 
live bean failure and a mitral valve oroaberir. We have titrated an 
initial dose of 2CQ mglday down lb Ihe IOWCSL dose possible to 
conlrol the venucular response. The rewltad slowing of heart rate 
has caused an mcreax in diastolic filling period and we then place 
the padem on a maintenance dosage or ar little ar 100 m#3 dmer a 
week. We have also controlled the arrhylhmia orpatients uilhout a 
mitral valve pronhesis who had atrial fibrillation wilh a rapid 
ventricular response. In both sets of pelients the arrhythmia had 
oreviouslv been uncontrolled with dieoxin lheraov. We then used 
nf control or the r&id atrial Rbrill&n and obseived 
improvernerd in exercise lolersnce. We have also treated an elderly 
palienl who was bcdriddw with refmctory congerlive hean fadore 
but now lives indewendendv at home. If side ctTeclr dewloo. the 
atria1 arrhylbmls\. \re have found it of little benefit in pa!ienlr with 
congertive hean redore brwse 01 iIs negalive inotropic eRect. 
